Skip to main content
Contact Us
Subscribe
E-Edition
62°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
2025 Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Pfizer
(NY:
PFE
)
25.09
+0.14 (+0.58%)
Streaming Delayed Price
Updated: 3:56 PM EST, Nov 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Pfizer
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 5% Dividend Yields
Today 9:49 EST
Via
Benzinga
2 Beaten-Down Healthcare Stocks to Buy Hand Over Fist
Today 8:15 EST
Via
The Motley Fool
2 Dividend Stocks That Pay More Than 6% That Retirees Can Safely Buy and Hold for Years
Today 4:25 EST
Via
The Motley Fool
Pfizer Unusual Options Activity For November 20
November 20, 2024
Via
Benzinga
Mutated Bird Flu Case In California Puts Humans At Increased Risk, So Which Companies Are Developing Vaccines?
November 20, 2024
According to the Los Angeles Times, the total bird flue case count in the U.S. stands at 54; 31 cases are attributed to the dairy industry.
Via
Benzinga
Pfizer Announces New Chief Scientific Officer and President, Research & Development
November 20, 2024
From
Pfizer Inc.
Via
Business Wire
Is It Time to Sell Eli Lilly and Pfizer Stocks?
November 20, 2024
Via
The Motley Fool
European Commission Approves Pfizer’s HYMPAVZI™ (marstacimab) for the Treatment of Adults and Adolescents with Severe Hemophilia A or B Without Inhibitors
November 20, 2024
From
Pfizer Inc.
Via
Business Wire
BridgeBio Pharma's Acoramidis Shows Competitive Edge Against Pfizer's Tafamidisa In Lucrative But Competitive ATTR-CM Market
November 19, 2024
BridgeBio's acoramidis shows significant reductions in mortality and hospitalizations in ATTR-CM patients, with no new safety concerns in long-term studies.
Via
Benzinga
2 High-Yield Dividend Stocks I Can't Stop Buying
November 18, 2024
Via
The Motley Fool
Not-So-Big Pharma
November 16, 2024
Thanks to the change in the Health and Human Services Department, 'big pharma' stocks are one of the very few sectors in equity-land that are seemingly unhappy about the forthcoming administration.
Via
Talk Markets
Stock Of The Day: Is Pfizer Set Up To Rally?
November 15, 2024
Shares of Pfizer (PFE) may be about to reverse and head higher. They are both oversold and at a support level.
Via
Benzinga
Unpacking the Latest Options Trading Trends in Pfizer
November 15, 2024
Via
Benzinga
Key Takeaways From Pfizer Analyst Ratings
November 15, 2024
Via
Benzinga
ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
November 16, 2024
ORIC Pharmaceuticals is a stock analyst price targets currently signal double-bagger potential in. See what the excitement around this firm is all about.
Via
MarketBeat
Friday's Top 5 Trending Stocks: What's The Scoop On Palantir, Bloom Energy, Pfizer?
November 15, 2024
Here's a look at Pfizer, Applied Materials, Bloom Energy, Palantir and FuelCell Energy. Friday's Top 5 Trending Stocks.
Via
Benzinga
Powell Speaks The Truth - Market Does Not Like It, Consternation About Kennedy, Gaetz, And Hegseth
November 15, 2024
To gain an edge, this is what you need to know today.
Via
Benzinga
European And US Vaccine Stocks Are Under Pressure - Here's WHy
November 15, 2024
Vaccine stocks react to Robert F. Kennedy Jr.'s HHS nomination. FDA and NIH express concerns over his anti-vaccine views amid market shifts.
Via
Benzinga
Exposures
Product Safety
Pfizer, Moderna, Novavax Take A Beating After Trump Taps Kennedy To Head Up HHS
November 15, 2024
President-elect Donald Trump tapped widely known vaccine skeptic Robert F. Kennedy Jr. to lead the Department of Health and Human Services.
Via
Investor's Business Daily
Topics
Government
Exposures
Political
WHO Calls Vaccines 'Absolutely Critical' As Trump's Appointment Of RFK Jr Pulls Pzifer, Moderna Stocks Downhill
November 15, 2024
Trump's decision to appoint Kennedy, known for his vaccine skepticism, has sparked significant attention.
Via
Benzinga
Topics
Government
Exposures
Political
This Johnson & Johnson Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
November 15, 2024
Via
Benzinga
US Stocks Likely To Open In Red After Jerome Powell Says No Need To Be 'In A Hurry' On Rate Cuts: Tesla, TSMC And Domino's In Focus
November 15, 2024
U.S. stocks could open on a negative note on Friday after the Federal Reserve chair Jerome Powell's comments on Thursday that the economy is showing enough strength that there is no need to be "in a...
Via
Benzinga
Topics
Economy
Exposures
Economy
Interest Rates
Palantir, Moderna, Pfizer, Alibaba, Tesla: Why These 5 Stocks Are On Investors' Radars Today
November 14, 2024
US stock market experienced a downward trend on Thursday, with both the Nasdaq Composite and the S&P 500 indices falling by nearly 0.6% respectively.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Trump Taps RFK Jr. For Health Secretary Role, Sends 5 Vaccine Stocks Lower
November 14, 2024
Trump may appoint Robert F. Kennedy Jr. as HHS Secretary, stirring mixed reactions. Kennedy's views on vaccines could reshape policies and affect vaccine stocks.
Via
Benzinga
Topics
Government
Exposures
Political
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
November 14, 2024
From
Pfizer Inc.
Via
Business Wire
The Oncology Bet Is Already Paying Off For Pfizer
November 13, 2024
With the downfall of Covid-19, pharmaceutical companies turned to oncology in search for their next growth story. Earlier in October, Pfizer Inc (NYSE: PFE) reported its third quarter revenue grew 14%...
Via
Benzinga
Exposures
COVID-19
Bird Flu Puts Teen In Critical Condition As Canada Reports First Human Case: What You Need To Know
November 13, 2024
Pfizer and Moderna are hustling to develop an mRNA bird flu vaccine, the same technology used in the companies' respective COVID-19 vaccines.
Via
Benzinga
Exposures
COVID-19
3 Stocks Seeing Insider Buys: CNC, PFE, BMY
November 12, 2024
Investors closely monitor insider buys, as they can give hints surrounding the long-term picture. Let’s take a closer look at the transactions for those interested in trading like the insiders.
Via
Talk Markets
10 Health Care Stocks Whale Activity In Today's Session
November 12, 2024
Via
Benzinga
Biotech Stocks Are Rallying: What Is Your Playbook?
November 11, 2024
If you have been reading our posts you know that some of the big biotech winners have taken a hit after earnings : LLY, MRK and REGN. But ABBV, GILD, LLY, and VRTX remain among the top performers.
Via
Talk Markets
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.